Tabituximab barzuxetan yttrium Y-90

DB17982ExperimentalProtein Based Therapies

A version of tabituximab barzuxetan radiolabeled with yttrium-90.

Code names
OTSA-101-DTPA-Y90

Resolves to

Compound
UNII1Q6DY14GVO

Which companies are running trials of Tabituximab barzuxetan yttrium Y-90, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In